Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
90 hedge funds and large institutions have $2.11B invested in Allergan plc in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 44 reducing their positions, and 29 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
15% less funds holding
Funds holding: 106 → 90 (-16)
25% less capital invested
Capital invested by funds: $2.81B → $2.11B (-$702M)
55% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 29
59% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$128M |
| 2 |
ES
Equitec Specialists
Chicago,
Illinois
|
+$52.6M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$39.3M |
| 4 |
JP Morgan Chase
New York
|
+$17.7M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$17.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$127M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$79.2M |
| 3 |
LCM
Lakewood Capital Management
New York
|
-$66.5M |
| 4 |
ACM
Advent Capital Management
New York
|
-$48.9M |
| 5 |
Neuberger Berman Group
New York
|
-$33.6M |
AGN.PRA Hedge Fund Activity: Q4 2017 in Review
90 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q4 2017, worth a combined $2.11B — down 25% from $2.81B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of AGN.PRA and 13 opened new positions — a net loss of 16 holders — while 44 trimmed existing stakes and 18 added.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $128M. The largest seller was Sculptor Capital, exiting entirely with an estimated $127M sold.
- 90 institutional investors held Allergan plc (AGN.PRA) as of Q4 2017, down from 106 in Q3 2017.
- Funds reported $2.11B of Allergan plc stock for Q4 2017, down 25% quarter-over-quarter.
- 13 funds opened new Allergan plc positions in Q4 2017 and 29 closed out, a net change of -16 holders.
- The largest Allergan plc buyer in Q4 2017 was Weiss Asset Management, an estimated $128M added.
- The largest Allergan plc seller in Q4 2017 was Sculptor Capital, an estimated $127M sold.
Based on aggregated 13F filings for Q4 2017.